Author details

Full Name

Mary Beth Terry

Affiliation

ORCID

Career Start Year

1995

Papers

433

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38010586	Blood DNA methylation and liver cancer in American Indians: evidence from the Strong Heart Study.	Cancer Causes Control	2024
36781224	Epidemiology and Risk Factors for Breast Cancer: 21st Century Advances, Gaps to Address through Interdisciplinary Science.	Cold Spring Harb Perspect Med	2023
35613015	Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk.	Int J Epidemiol	2023
36129804	Dietary Factors and Early-Onset Colorectal Cancer in the United States-an Ecologic Analysis.	Cancer Epidemiology Biomarkers and Prevention	2023
37611220	Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.	J Clin Oncol	2023
37767192	Psychological, behavioural, and physical aspects of caregiver strain in autism-caregivers: a cohort study.		2023
37338197	Immigrant generation status and its association with pubertal timing and tempo among Hispanic girls and boys.	Am J Hum Biol	2023
37209183	Breast cancer risk prediction combining a convolutional neural network-based mammographic evaluation with clinical factors.	Breast Cancer Res Treat	2023
36823754	High-throughput measurement of double strand break global repair phenotype in peripheral blood mononuclear cells after long-term cryopreservation.		2023
37461559	Improved prediction of breast cancer risk based on phenotypic DNA damage repair capacity in peripheral blood B cells.		2023
36565401	Correction to: Current regular aspirin use andÂ mammographic breast density: aÂ cross-sectional analysis considering concurrent statin andÂ metformin use.		2023
37436425	Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood.		2023
36857773	Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry.	Cancer Epidemiol Biomarkers Prev	2023
37224940	Prenatal airborne polycyclic aromatic hydrocarbon exposure, altered regulation of peroxisome proliferator-activated receptor gamma (Ppar)Î³, and links with mammary cancer.		2023
37541535	Risk factors for developing both primary breast and primary ovarian cancer: A systematic review.		2023
36913517	Reassessing the causal role of early-life adiposity in breast cancer: could the apparent inverse associations be a manifestation of survival bias?		2023
35157067	Body mass index rebound and pubertal timing in girls with and without a family history of breast cancer: the LEGACY girls study.	Int J Epidemiol	2022
35849397	Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.	JAMA Netw Open	2022
35898117	Cancer Education Interventions in Adolescents: A Systematic Review of Scope and Content.	Health Education and Behavior	2022
36227532	Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.	Journal of Community Genetics	2022
35895514	Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons and Timing of Pubertal Development: The California PAH Study.	Epidemiology	2022
35821060	Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study.	Breast Cancer Research	2022
35819548	Experience of a National Cancer Institute-Designated Community Outreach and Engagement Program in Supporting Communities During the COVID-19 Pandemic.	Journal of Community Health	2022
36077659	Evidence-Based Interventions for Reducing Breast Cancer Disparities: What Works and Where the Gaps Are?	Cancers	2022
35941279	A comparison of various methods for measuring breast density and breast tissue composition in adolescent girls and women.	Sci Rep	2022
36205748	Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.	Genet Med	2022
36328784	Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.	Br J Sports Med	2022
35777474	Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk.	J Pediatr	2022
36544225	Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort.	Breast Cancer Res	2022
33523407	Cancer Risk Reduction Through Education of Adolescents: Development of a Tailored Cancer Risk-Reduction Educational Tool.	Journal of Cancer Education	2022
35319016	Do current family history-based genetic testing guidelines contribute to breast cancer health inequities?	npj Breast Cancer	2022
35048954	Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.	J Natl Cancer Inst	2022
35042965	Rare germline copy number variants (CNVs) and breast cancer risk.	Commun Biol	2022
34453225	E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk.	Journal of Community Health	2022
35253046	The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver?	Cancer Epidemiology Biomarkers and Prevention	2022
35233009	DNA repair phenotype and cancer risk: a systematic review and meta-analysis of 55 case-control studies.	Scientific Reports	2022
34906967	Air Pollution and Breast Cancer: An Examination of Modification By Underlying Familial Breast Cancer Risk.	Cancer Epidemiology Biomarkers and Prevention	2022
34906479	Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.	Genet Med	2022
34851324	A Clinical Risk Model for Surgical Site Infection Following Pediatric Spine Deformity Surgery.	J Bone Joint Surg Am	2022
34965921	Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC).	Cancer Prev Res (Phila)	2022
35022893	Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use.	Cancer Causes and Control	2022
34896321	Predictors of urinary polycyclic aromatic hydrocarbon metabolites in girls from the San Francisco Bay Area.	Environmental Research	2022
35114472	Improvement on recovery and reproducibility for quantifying urinary mono-hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs).	Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences	2022
35077220	Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants.	J Clin Oncol	2022
34950851	Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk.	JNCI Cancer Spectr	2021
33811170	Breast Tissue Composition-Why It Matters and How Can We Measure It More Accurately in Epidemiology Studies.	Cancer Epidemiology Biomarkers and Prevention	2021
33811169	Less Is More-Ways to Move Forward for Improved Breast Cancer Risk Stratification.	Cancer Epidemiology Biomarkers and Prevention	2021
33909208	Symposium report: breast cancer in India-trends, environmental exposures and clinical implications.	Cancer Causes and Control	2021
34287740	Is it 'cancer prevention' or 'risk reduction'? #Wordsmatter.	Cancer Causes and Control	2021
34232831	A competing risks model with binary time varying covariates for estimation of breast cancer risks in <i>BRCA1</i> families.	Stat Methods Med Res	2021